Document is current

Any future updates will be listed below

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease

Crossref DOI link: https://doi.org/10.1186/s12933-018-0760-6

Published Online: 2018-08-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark